Funding arb · Price arb / RWA
| Leg | Exchange | Price | Fund. /8h | Each payment | Next in | OI | Vol 24h | Lev | |
|---|---|---|---|---|---|---|---|---|---|
| LONG | 1,393.3 | +0.0108 | pay 0.0014% / 1h | 2m 18s | $6.2M | $3.8M | 10x | Long tradeXYZ | |
| SHORT | 1,396.3 | 0 | 0.0000% / 1h | 2m 18s | $208K | $401K | 10x | Short RISExInvite |
Price gap+0.214%
Funding gap−0.0108% /8h
The gap pays +$18 on $10k if it goes back to its 7d average, but funding costs $3 a day and eats that in about 5.5 days. At the last 7 days' pace that is about 2.6 days.
If you open now and hold
on $10k a leg · figures of the last 7D, not a forecastFunding−$49−0.0108% /8h now · paid −0.488% over the last 7D
Price+$18spread +0.214% now, avg +0.035% → +0.179% if it goes back
Costs−$180.184% of $10k · taker + slippage, in and out
Price and funding
1h · historyEntry / Exit
Price spread
Prices
Fundingper 8h
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now+0.214%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—
Where the spread has been, last 7D▾
share of time at each level
Funding on every exchange
/8hLLY on 24 exchanges
lowest funding firstBefore you open
5 ok · 1 to watch- OK: Fits both order books4.6 / 4.1 bpEntry at $10k a leg, taker fee + slippage. Closing costs about the same.
- Note: Margin at max leverage$1,000 + $1,000tradeXYZ 10x, RISEx 10x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
- OK: Same payment interval1h / 1hBoth legs pay at the same time.Next 24h at the current rates, on $10k a leg: −$3.24Long tradeXYZ: 24 payments, −$3.24; short RISEx: 24 payments, $0.00.
- OK: Entry gap works for you+0.214% vs +0.035%You short the dearer leg. If the gap goes back to average, the short gains.
- Watch: Short leg is thinner$208K vs $6.2M OIRISEx sets your exit cost. Check its book before closing.
- OK: Points on a legtradeXYZ pointsVolume here counts toward the points program.
- OK: No KYC on either legtradeXYZ No · RISEx NoBoth exchanges let you trade without ID.
Profit calculator
both legs, in and outPosition, each legHold forOrdersPrice spreadFunding rate
Funding earned−0.0232%/8h × 21 periods−$48.76
Price spread+0.214% → +0.035% (7d avg)+$17.88
Slippage, 4 orderslive order books−$10.59
Fee tradeXYZ bp × 2 orders−$1.80
Fee RISEx bp × 2 orders−$6.00
Net · 7 days · $10k−$49.28
Costs to cover0.184%Break-evennever at this rate
Slippage: tradeXYZ: live order book, 9 min ago; RISEx: live order book, 9 min agoCost to enter
taker + slippage from mid, one sideBUY · LONGtradeXYZ2.874.6 bp−$515.3 bp−$15383.9 bp−$8,386doesn’t fit
SELL · SHORTRISEx1.114.1 bp−$48.2 bp−$82doesn’t fitdoesn’t fit
Closing costs about the same again.
LLY news
posts that mention LLY, from every exchange| 11-05 13:43 | Kalshi | Listing | new market KXLLYPERP ($LLY) seen by our collector |
| 11-04 16:45 | Arcus | Listing | new market LLY-USD ($LLY) seen by our collector |
| 10-30 09:00 | MEXC | Other | 💊 Health care shines as tech stocks slide! 🟢 $LLY: +6% | Q3 revenue: +39% 🟢 Health care ETF: +2.40% 🔴 Nasdaq: -1.38% | Tech ETF: -1.18% Health care earnings stood out amid the tech selloff. One-day rotation or a bigger market shift? 👇 @MEXC on X ↗ |
| 10-29 13:26 | RISEx | Points | Eli Lilly, the drugmaker, is now live on RISEx at 10x Q3 revenue came in at $24.4B against about $22.6B expected, and Lilly raised its 2026 guidance to $91B to $92B. $LLY is part of Print Week, so enjoy a 20% points boost as well @risextrade on X ↗ |
| 10-29 13:16 | Phoenix | Other | Eli Lilly reports Q3 revenue of $24.4B, up 39%, and raises its full-year revenue guidance to $92B. $LLY is trading at $1,349 on Phoenix, 24/7. @PhoenixTrade on X ↗ |
| 10-28 21:06 | Phoenix | Other | $LLY reports tomorrow before the open. Analyst consensus is $6.67 EPS on $22.62B in revenue. Today, Lilly said retatrutide beat Ozempic head-to-head in a Phase 3 type 2 diabetes trial. Trade $LLY on Phoenix, 24/7. @PhoenixTrade on X ↗ |


Kalshi
MEXC
Phoenix